Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
ID:
Password:
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

Agents/Distributors
 Regional Subscription Agents/Distributors
 
Trends in Cancer Research   Volumes    Volume 14 
Abstract
Cisplatin sensitivity-enhancing effects of phytochemicals on the cisplatin-resistant human epidermoid carcinoma KCP-4 cell line
Shigeru Oiso, Mayo Kuwaduru, Mako Koyanagi, Haruka Takatsutsumi, Kodai Kawamoto, Takuhiro Uto, Ryuji Ikeda, Hiroko Kariyazono
Pages: 57 - 65
Number of pages: 9
Trends in Cancer Research
Volume 14 

Copyright © 2019 Research Trends. All rights reserved

ABSTRACT
 
Cisplatin, an effective anti-cancer agent, is used for the treatment of various cancers. However, resistance to cisplatin often disrupts chemotherapy, and efforts have been made to identify compounds that enhance sensitivity of cancer cells to this drug. We previously reported that curcumin enhances the sensitivity of the high-level cisplatin-resistant human epidermoid carcinoma cell line, KCP-4. Other phytochemicals, such as corosolic acid, epigallocatechin gallate (EGCG), and noscapine have been reported to enhance the cisplatin sensitivity of lung and ovarian cancer cells, but it is unclear whether they alter cisplatin resistance of KCP-4 cells. There is also no comparative study of the effects of the above-mentioned compounds administered under the same experimental conditions in the same cell line. In this study, we compared the effects of corosolic acid, curcumin, EGCG, and noscapine on cisplatin sensitivity of KCP-4 cells under controlled conditions. Upon administration of the maximum non-toxic concentration of each compound, curcumin, EGCG, and noscapine, but not corosolic acid, could significantly enhance the cisplatin sensitivity of KCP-4 cells, with the greatest improvement identified in curcumin-treated cells. Curcumin and noscapine were found to suppress nuclear factor-kappa B activation, which when undisrupted, contributes to cisplatin resistance in KCP-4 cells. Curcumin also downregulated Bcl-2 and survivin, and EGCG downregulated survivin. Corosolic acid and noscapine however had no significant effect on the expression of Bcl-2, Bcl-xL, and survivin. Our results suggest that of all compounds tested, curcumin could be the most excellent candidate for enhancing the sensitivity of cisplatin-resistant cancer cells.
Buy this Article


 
search


E-Commerce
Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Login
Search Products
Browse in Alphabetical Order : Journals
Series/Books
Browse by Subject Classification : Journals
Series/Books

Miscellaneous
Ordering Information Ordering Information
Downloadable forms Downloadable Forms